企業プロフィール
Amphastar Pharmaceuticals, Inc. 株価・ニュース・カタリスト
- ティッカー:
- AMPH
- 取引所:
- NASDAQ
- セクター:
- Pharmaceuticals
- 所在地:
- United States
株価パフォーマンス
25.35 USD (-1.78%)
終値
最終更新: 2026年10月1日
814M USD
時価総額
株価変動の要因
2026年10月1日 時点で AMPH は 1.78% 下落し、$25.35 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Specialty Pharmaceutical Manufacturer
Amphastar Pharmaceuticals develops, manufactures, and commercializes technically challenging injectable, inhaled, intranasal, and other pharmaceutical products. Its portfolio combines proprietary brands, complex generics, active pharmaceutical ingredients, and selected biosimilar programs.
Proprietary Products
The company's branded products include BAQSIMI nasal glucagon, Primatene MIST, REXTOVY, Amphadase, and Cortrosyn. These products give Amphastar direct exposure to diabetes rescue, respiratory care, opioid overdose, diagnostic use, and other specialty markets.
Complex Generic Medicines
Amphastar supplies sterile injectables and other complex generics that require specialized development, manufacturing, and regulatory capabilities. Its products are distributed through wholesalers, retailers, hospitals, and group purchasing organizations.
Integrated Manufacturing and APIs
The company manufactures active pharmaceutical ingredients through its ANP subsidiary and operates finished-dose facilities for sterile and nonsterile products. Vertical integration supports supply control, product economics, and development of medicines with technically demanding formulations or devices.
Biosimilar and Proprietary Pipeline
The pipeline includes a filed biosimilar insulin candidate, an additional filed abbreviated new drug application, other biosimilar and generic programs, and in-licensed proprietary peptides for oncology and ophthalmology. Amphastar is also developing a fully synthetic corticotropin compound for inflammatory and autoimmune diseases.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。